MAXIM PHARMACEUTICALS, INC

Organization

SAN DIEGO, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for promoting the maturation of monocytes
- Patent number 6,893,633
- Issue date May 17, 2005
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for promoting the maturation of monocytes
- Patent number 6,821,510
- Issue date Nov 23, 2004
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for promoting the maturation of monocytes
- Patent number 6,790,440
- Issue date Sep 14, 2004
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment and prevention of reactive oxygen metabolite-mediated cel...
- Patent number 6,730,692
- Issue date May 4, 2004
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of histamine dihydrochloride
- Patent number 6,620,942
- Issue date Sep 16, 2003
- Maxim Pharmaceuticals
- Wen-Lung Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Elevation of circulating blood histamine levels
- Patent number 6,613,788
- Issue date Sep 2, 2003
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ophthalmic histamine compositions and uses thereof
- Patent number 6,531,120
- Issue date Mar 11, 2003
- Maxim Pharmaceuticals, Inc.
- Kurt R. Gehlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of histamine dihydrochloride
- Patent number 6,528,654
- Issue date Mar 4, 2003
- Maxim Pharmaceuticals, Inc.
- Wen-Lung Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synergistic tumorcidal response induced by histamine
- Patent number 6,498,181
- Issue date Dec 24, 2002
- Maxim Pharmaceuticals
- Kurt R. Gehlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prevention of reactive oxygen metabolite-mediated cel...
- Patent number 6,462,067
- Issue date Oct 8, 2002
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prevention of reactive oxygen metabolite-mediated cel...
- Patent number 6,407,133
- Issue date Jun 18, 2002
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of histamine dihydrochloride
- Patent number 6,403,806
- Issue date Jun 11, 2002
- Maxim Pharmaceuticals, Inc.
- Wen-Lung Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enhanced activation of natural killer cells using an NK cell activa...
- Patent number 6,375,946
- Issue date Apr 23, 2002
- Maxim Pharmaceuticals, Inc.
- Jan Urban Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for topical treatment of damaged tissue us...
- Patent number 6,350,785
- Issue date Feb 26, 2002
- Maxim Pharmaceuticals, Inc.
- Kurt R. Gehlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treatment of cancer and infectious disease
- Patent number 6,305,380
- Issue date Oct 23, 2001
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and compositions for topical treatment of damaged tissue usi...
- Patent number 6,270,781
- Issue date Aug 7, 2001
- Maxim Pharmaceuticals, Inc.
- Kurt R. Gehlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced activation of natural killer cells using an NK cell activa...
- Patent number 6,245,563
- Issue date Jun 12, 2001
- Maxim Pharmaceuticals, Inc.
- Jan Urban Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prevention of reactive oxygen metabolite-mediated cel...
- Patent number 6,242,473
- Issue date Jun 5, 2001
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Administration of histamine for therapeutic purposes
- Patent number 6,221,893
- Issue date Apr 24, 2001
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treatment of cancer and infectious disease
- Patent number 6,155,266
- Issue date Dec 5, 2000
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and composition for topical treatment of damaged tissue usin...
- Patent number 6,080,395
- Issue date Jun 27, 2000
- Maxim Pharmaceutical, Inc.
- Bruce A. Jack
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced activation of natural killer cells using an NK cell activa...
- Patent number 6,071,509
- Issue date Jun 6, 2000
- Maxim Pharmaceuticals, Inc.
- Jan Urban Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Elevation of circulating blood histamine levels
- Patent number 6,071,942
- Issue date Jun 6, 2000
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced activation of NK cells using an NK cell activator and a hy...
- Patent number 6,063,373
- Issue date May 16, 2000
- Maxim Pharmaceuticals, Inc.
- Jan Urban Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treatment of cancer and infectious disease
- Patent number 6,003,516
- Issue date Dec 21, 1999
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable circulating histamine levels
- Patent number 5,961,969
- Issue date Oct 5, 1999
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation for activation of natural killer cells (NK-cells), said...
- Patent number 5,728,378
- Issue date Mar 17, 1998
- Maxim Pharmaceuticals, Inc.
- Kristoffer Hellstrand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides for detecting antibodies to HTLV-2
- Patent number 5,670,311
- Issue date Sep 23, 1997
- Maxim Pharmaceuticals, Inc.
- Anders Vahlne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
85021009 - CEPLENE
- Serial number 85021009
- Registration number 4214414
- Filing date Apr 22, 2010
- Maxim Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78452047 - MAXAMINE
- Serial number 78452047
- Filing date Jul 16, 2004
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76138210 - LIVANAR
- Serial number 76138210
- Filing date Sep 29, 2000
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76138211 - VONTIV
- Serial number 76138211
- Registration number 3252103
- Filing date Sep 29, 2000
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76138212 - CEPLENE
- Serial number 76138212
- Registration number 2967403
- Filing date Sep 29, 2000
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76138213 - KIVRAN
- Serial number 76138213
- Filing date Sep 29, 2000
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75907741 - MAXIM PHARMACEUTICALS
- Serial number 75907741
- Registration number 2425162
- Filing date Feb 3, 2000
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75146908 - MAXVAX
- Serial number 75146908
- Filing date Aug 8, 1996
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75146909 - MAXAMINE
- Serial number 75146909
- Registration number 2182777
- Filing date Aug 8, 1996
- MAXIM PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 4

Research Projects

Information Research Project
MX2060: A novel apoptosis-inducing antitumor agent
- Application id 6710175
- Award notice date Mar 1, 2004
Information Research Project
APOPTOSIS-INDUCING ANTIMITOTIC AGENTS FOR CANCER THERAPY
- Application id 6298857
- Award notice date Feb 21, 2001
Information Research Project
CV2060: A NOVEL APOPTOSIS-INDUCING ANTI-TUMOR AGENT
- Application id 6354363
- Award notice date Sep 27, 2000
Information Research Project
MX2060: A novel apoptosis-inducing antitumor agent
- Application id 6583423

MAXIM PHARMACEUTICALS, INC

Organization

Patents Grantslast 30 patents

Methods and compositions for promoting the maturation of monocytes

Methods and compositions for promoting the maturation of monocytes

Methods and compositions for promoting the maturation of monocytes

Treatment and prevention of reactive oxygen metabolite-mediated cel...

Synthesis of histamine dihydrochloride

Elevation of circulating blood histamine levels

Ophthalmic histamine compositions and uses thereof

Synthesis of histamine dihydrochloride

Synergistic tumorcidal response induced by histamine

Treatment and prevention of reactive oxygen metabolite-mediated cel...

Treatment and prevention of reactive oxygen metabolite-mediated cel...

Synthesis of histamine dihydrochloride

Enhanced activation of natural killer cells using an NK cell activa...

Methods and compositions for topical treatment of damaged tissue us...

Method for treatment of cancer and infectious disease

Method and compositions for topical treatment of damaged tissue usi...

Enhanced activation of natural killer cells using an NK cell activa...

Treatment and prevention of reactive oxygen metabolite-mediated cel...

Administration of histamine for therapeutic purposes

Method for treatment of cancer and infectious disease

Method and composition for topical treatment of damaged tissue usin...

Enhanced activation of natural killer cells using an NK cell activa...

Elevation of circulating blood histamine levels

Enhanced activation of NK cells using an NK cell activator and a hy...

Method for treatment of cancer and infectious disease

Stable circulating histamine levels

Preparation for activation of natural killer cells (NK-cells), said...

Peptides for detecting antibodies to HTLV-2

Trademarklast 30 trademarks

85021009 - CEPLENE

78452047 - MAXAMINE

76138210 - LIVANAR

76138211 - VONTIV

76138212 - CEPLENE

76138213 - KIVRAN

75907741 - MAXIM PHARMACEUTICALS

75146908 - MAXVAX

75146909 - MAXAMINE

NIH Research Projectlast 12 months

Research Projects

MX2060: A novel apoptosis-inducing antitumor agent

APOPTOSIS-INDUCING ANTIMITOTIC AGENTS FOR CANCER THERAPY

CV2060: A NOVEL APOPTOSIS-INDUCING ANTI-TUMOR AGENT

MX2060: A novel apoptosis-inducing antitumor agent